FIELD: medicine. SUBSTANCE: bacterial mass of culture BCG-M grown in solid potato medium and then in liquid synthetic media is removed, filtered, washed out with drying medium, ground in shuttle-apparatus to obtain homogeneous mass, diluted with stabilizing agent to prepare suspension containing 50 mg of BCG/1 ml followed by centrifugation at 2 000 rev/min for 15-20 min. Then supernatant suspension is diluted again to the final concentration 0.5 mg BCG/1 ml. Vaccine is ampouled and lyophilized. EFFECT: enhanced viability in single vaccinating dose. 1 cl, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING VACCINE BCG "IMURON" FOR BLADDER CANCER IMMUNOTHERAPY | 1999 |
|
RU2170103C1 |
METHOD OF STREPTOCOCCUS HYALURONIDASE PREPARING | 2000 |
|
RU2174557C1 |
METHOD OF PREPARING PURIFIED LIQUID STAPHYLOCOCCUS ANATOXIN FOR SPECIFIC IMMUNOTHERAPY OF PATIENTS WITH STAPHYLOCOCCUS INFECTION | 2000 |
|
RU2169580C1 |
METHOD FOR PREPARING PROBIOTICS | 2002 |
|
RU2205650C1 |
METHOD FOR LYOPHILIC DRYING OF ATTENUATED BACTERIA B.PERTUSSIS, ATTENUATED BACTERIA B. PERTUSSIS, STRAIN OF ATTENUATED B. PERTUSSIS BACTERIA, VACCINE, LYOPHILIZED VACCINE PREPARATION | 2017 |
|
RU2709657C2 |
OINTMENT FOR PYODERMIA TREATMENT | 1999 |
|
RU2169554C1 |
GEL FOR WOUND TREATMENT | 1999 |
|
RU2169553C1 |
METHOD FOR PREVENTING BRUCELLOSIS | 1992 |
|
RU2037319C1 |
METHOD FOR DETECTING CYTOPROLIFERATIVE FACTOR IN AGING MAMMALIAN AND HUMAN BODIES IN THEIR LIFETIME | 2001 |
|
RU2204135C2 |
MIXED ANTHRAX VACCINE | 1992 |
|
RU2115433C1 |
Authors
Dates
2001-07-20—Published
2000-02-22—Filed